Biofactories: engineered nanoparticles via genetically engineered organisms
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F19%3A73595317" target="_blank" >RIV/61989592:15310/19:73595317 - isvavai.cz</a>
Výsledek na webu
<a href="https://pubs.rsc.org/en/content/articlehtml/2019/gc/c9gc01759c" target="_blank" >https://pubs.rsc.org/en/content/articlehtml/2019/gc/c9gc01759c</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/c9gc01759c" target="_blank" >10.1039/c9gc01759c</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Biofactories: engineered nanoparticles via genetically engineered organisms
Popis výsledku v původním jazyce
Nanoparticles and nanostructures are being applied in a diverse range of biomedical and pharmaceutical applications, including targeted drug- and gene-delivery systems, cancer therapy, anti-virus and antimicrobial agents, RNA and DNA analyses, biosensors, catalysis, and imaging. In the context of nanoparticles and their assembly, organism-centered biosynthesis propounds additional energy-efficiency, safer, greener, and environmentally-friendly protocols in contrast to the physico-chemical procedures necessitating the use of solvents and unsafe/toxic materials, often at elevated temperatures. Genetically engineered organisms can be applied as good candidates for greener, eco-friendly, expeditious, high-throughput, and versatile bioreduction systems for the synthesis and assembly of nanomaterials and NPs, even on the industrial scale. In terms of ideal attributes, they should be much more resistant to metal toxicity, grow rapidly in inexpensive simple media, produce higher yields of biomass and can be easily manipulated genetically. In this review, the latest advances in nanoparticle biosynthesis are highlighted with particular emphasis on the deployment of genetically engineered organisms. The challenges and future trends in this field are accentuated, where innovative and engineered approaches will be the most consequential.
Název v anglickém jazyce
Biofactories: engineered nanoparticles via genetically engineered organisms
Popis výsledku anglicky
Nanoparticles and nanostructures are being applied in a diverse range of biomedical and pharmaceutical applications, including targeted drug- and gene-delivery systems, cancer therapy, anti-virus and antimicrobial agents, RNA and DNA analyses, biosensors, catalysis, and imaging. In the context of nanoparticles and their assembly, organism-centered biosynthesis propounds additional energy-efficiency, safer, greener, and environmentally-friendly protocols in contrast to the physico-chemical procedures necessitating the use of solvents and unsafe/toxic materials, often at elevated temperatures. Genetically engineered organisms can be applied as good candidates for greener, eco-friendly, expeditious, high-throughput, and versatile bioreduction systems for the synthesis and assembly of nanomaterials and NPs, even on the industrial scale. In terms of ideal attributes, they should be much more resistant to metal toxicity, grow rapidly in inexpensive simple media, produce higher yields of biomass and can be easily manipulated genetically. In this review, the latest advances in nanoparticle biosynthesis are highlighted with particular emphasis on the deployment of genetically engineered organisms. The challenges and future trends in this field are accentuated, where innovative and engineered approaches will be the most consequential.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
21001 - Nano-materials (production and properties)
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
GREEN CHEMISTRY
ISSN
1463-9262
e-ISSN
—
Svazek periodika
21
Číslo periodika v rámci svazku
17
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
21
Strana od-do
4583-4603
Kód UT WoS článku
000483588100001
EID výsledku v databázi Scopus
2-s2.0-85071762948